Kidney Transplantation Clinical Trials

A listing of Kidney Transplantation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy

-5 chronic kidney disease (CKD) or dialysis-dependent end-stage kidney disease (ESKD) on patients' eligibility for kidney transplantation at the end of 9 months.

diabetes
heart failure
type 2 diabetes mellitus
kidney transplant
dialysis
  • 0 views
  • 26 Jul, 2021
  • 2 locations
Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection

Patients after kidney transplantation who develop donor-specific antibodies (DSA) are at high risk for antibody-mediated rejection (ABMR). Donor-derived cell-free DNA (dd-cfDNA) levels have been

  • 0 views
  • 01 Aug, 2021
Evaluation of Renal Pretransplant Serology for BK Virus on the Risk of Post-transplant Viral Reactivation

Due to the increasing importance of BKV infection on the survival of kidney transplants, a better knowledge, in the pretransplant phase, of the risk factors leading to viral reactivation could

kidney transplant
  • 0 views
  • 29 Jul, 2021
  • 1 location
Evaluation of Interaction Between Immunosuppressive Drugs and Protein-bound Uremic Toxins in Renal Transplant Patients

The majority of studies conducted on uremic toxins involve patients before end stage renal failure or dialysis patients. Only a few studies have focused on transplant patients. In addition, the relationship between serum concentrations of uremic toxins and immunosuppressive drug concentrations has never been studied to date. The investigator research …

  • 0 views
  • 25 Jul, 2021
  • 1 location
Stratified vs Routine Prophylaxis in Living Kidney Transplantation From HBsAg+ Donors to HBsAg- Recipients

clinical experience in living kidney transplantation from HBsAg+ donors to HBsAgrecipients. The follow-up period was 2 years after renal transplantation. The primary outcome was prevention failure of HBV

hepatitis b core antibody
  • 0 views
  • 29 Jul, 2021
  • 1 location